In oral cancer, sodium butyrate significantly lowers VEGF-C expression, inhibiting lymphatic vessel formation [165].Butyrate's multifaceted influence points to its role in mitigating cancer progression through the suppression of tumor angiogenesis and lymphangiogenesis, highlighting the preventative potential of dietary interventions. Here, VEGFC is linked to neoplasm.